Mar 25, 2025 · Rufinamide is a prescription medicine used with other medicines to treat seizures associated with Lennox-Gastaut Syndrome (LGS) in adults and pediatric patients 1 year of age and older.

Rufinamide is an anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome [3] and various other seizure disorders. Rufinamide, a triazole derivative, was developed in 2004 by Novartis Pharma, AG, and is manufactured by Eisai.

Jan 10, 2021 · Rufinamide is one of the anti-seizure drugs (ASD) used as an add-on therapy to treat seizures associated with Lennox Gastaut syndrome, and it is structurally unrelated to other traditional ASDs. This CME activity provides a brief and illustrative review of this drug's FDA-approved indications and pharmacodynamic and pharmacokinetic properties.

Rufinamide is in a class of medications called anticonvulsants. It works by decreasing abnormal excitement in the brain. How should this medicine be used? Rufinamide comes as a tablet to take by mouth. It is usually taken with food twice a day. Take rufinamide at …

Mar 1, 2025 · Rufinamide is used to control seizures (convulsions) that occur with Lennox-Gastaut syndrome (LGS). It works in the brain to prevent seizures. This medicine will not cure LGS and will only control seizures for as long as you continue to take it. This medicine is available only with your doctor's prescription.

BANZEL (rufinamide) is a prescription add-on medication approved for the treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in pediatric patients 1 year of age and older, and in adults. Patients with a history of Familial Short QT …

Rufinamide helps prevent brain cells from working as fast as a seizure requires them to. In this way, seizures can be stopped when they are just beginning. How does the body digest Rufinamide? After medicine is swallowed, it must be absorbed into the blood so it can move throughout the body.

Dec 2, 2024 · Detailed Rufinamide dosage information for adults and children. Includes dosages for Lennox-Gastaut Syndrome; plus renal, liver and dialysis adjustments.

Rufinamide oral suspension is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients 1 year of age and older and in adults.

View rufinamide information, including dose, uses, side-effects, pregnancy, breast feeding, important safety information and directions for administration.